SARS-CoV-2 infection and transmission in primary schools in England in June-December, 2020 (sKIDs): an active, prospective surveillance study.
Journal
The Lancet. Child & adolescent health
ISSN: 2352-4650
Titre abrégé: Lancet Child Adolesc Health
Pays: England
ID NLM: 101712925
Informations de publication
Date de publication:
06 2021
06 2021
Historique:
received:
14
01
2021
revised:
19
02
2021
accepted:
23
02
2021
pubmed:
20
3
2021
medline:
8
6
2021
entrez:
19
3
2021
Statut:
ppublish
Résumé
Little is known about the risk of SARS-CoV-2 infection and transmission in educational settings. Public Health England initiated a study, COVID-19 Surveillance in School KIDs (sKIDs), in primary schools when they partially reopened from June 1, 2020, after the first national lockdown in England to estimate the incidence of symptomatic and asymptomatic SARS-CoV-2 infection, seroprevalence, and seroconversion in staff and students. sKIDs, an active, prospective, surveillance study, included two groups: the weekly swabbing group and the blood sampling group. The swabbing group underwent weekly nasal swabs for at least 4 weeks after partial school reopening during the summer half-term (June to mid-July, 2020). The blood sampling group additionally underwent blood sampling for serum SARS-CoV-2 antibodies to measure previous infection at the beginning (June 1-19, 2020) and end (July 3-23, 2020) of the summer half-term, and, after full reopening in September, 2020, and at the end of the autumn term (Nov 23-Dec 18, 2020). We tested for predictors of SARS-CoV-2 antibody positivity using logistic regression. We calculated antibody seroconversion rates for participants who were seronegative in the first round and were tested in at least two rounds. During the summer half-term, 11 966 participants (6727 students, 4628 staff, and 611 with unknown staff or student status) in 131 schools had 40 501 swabs taken. Weekly SARS-CoV-2 infection rates were 4·1 (one of 24 463; 95% CI 0·1-21·8) per 100 000 students and 12·5 (two of 16 038; 1·5-45·0) per 100 000 staff. At recruitment, in 45 schools, 91 (11·2%; 95% CI 7·9-15·1) of 816 students and 209 (15·1%; 11·9-18·9) of 1381 staff members were positive for SARS-CoV-2 antibodies, similar to local community seroprevalence. Seropositivity was not associated with school attendance during lockdown (p=0·13 for students and p=0·20 for staff) or staff contact with students (p=0·37). At the end of the summer half-term, 603 (73·9%) of 816 students and 1015 (73·5%) of 1381 staff members were still participating in the surveillance, and five (four students, one staff member) seroconverted. By December, 2020, 55 (5·1%; 95% CI 3·8-6·5) of 1085 participants who were seronegative at recruitment (in June, 2020) had seroconverted, including 19 (5·6%; 3·4-8·6) of 340 students and 36 (4·8%; 3·4-6·6) of 745 staff members (p=0·60). In England, SARS-CoV-2 infection rates were low in primary schools following their partial and full reopening in June and September, 2020. UK Department of Health and Social Care.
Sections du résumé
BACKGROUND
Little is known about the risk of SARS-CoV-2 infection and transmission in educational settings. Public Health England initiated a study, COVID-19 Surveillance in School KIDs (sKIDs), in primary schools when they partially reopened from June 1, 2020, after the first national lockdown in England to estimate the incidence of symptomatic and asymptomatic SARS-CoV-2 infection, seroprevalence, and seroconversion in staff and students.
METHODS
sKIDs, an active, prospective, surveillance study, included two groups: the weekly swabbing group and the blood sampling group. The swabbing group underwent weekly nasal swabs for at least 4 weeks after partial school reopening during the summer half-term (June to mid-July, 2020). The blood sampling group additionally underwent blood sampling for serum SARS-CoV-2 antibodies to measure previous infection at the beginning (June 1-19, 2020) and end (July 3-23, 2020) of the summer half-term, and, after full reopening in September, 2020, and at the end of the autumn term (Nov 23-Dec 18, 2020). We tested for predictors of SARS-CoV-2 antibody positivity using logistic regression. We calculated antibody seroconversion rates for participants who were seronegative in the first round and were tested in at least two rounds.
FINDINGS
During the summer half-term, 11 966 participants (6727 students, 4628 staff, and 611 with unknown staff or student status) in 131 schools had 40 501 swabs taken. Weekly SARS-CoV-2 infection rates were 4·1 (one of 24 463; 95% CI 0·1-21·8) per 100 000 students and 12·5 (two of 16 038; 1·5-45·0) per 100 000 staff. At recruitment, in 45 schools, 91 (11·2%; 95% CI 7·9-15·1) of 816 students and 209 (15·1%; 11·9-18·9) of 1381 staff members were positive for SARS-CoV-2 antibodies, similar to local community seroprevalence. Seropositivity was not associated with school attendance during lockdown (p=0·13 for students and p=0·20 for staff) or staff contact with students (p=0·37). At the end of the summer half-term, 603 (73·9%) of 816 students and 1015 (73·5%) of 1381 staff members were still participating in the surveillance, and five (four students, one staff member) seroconverted. By December, 2020, 55 (5·1%; 95% CI 3·8-6·5) of 1085 participants who were seronegative at recruitment (in June, 2020) had seroconverted, including 19 (5·6%; 3·4-8·6) of 340 students and 36 (4·8%; 3·4-6·6) of 745 staff members (p=0·60).
INTERPRETATION
In England, SARS-CoV-2 infection rates were low in primary schools following their partial and full reopening in June and September, 2020.
FUNDING
UK Department of Health and Social Care.
Identifiants
pubmed: 33740430
pii: S2352-4642(21)00061-4
doi: 10.1016/S2352-4642(21)00061-4
pmc: PMC9764982
pii:
doi:
Substances chimiques
Antibodies, Viral
0
Types de publication
Journal Article
Research Support, Non-U.S. Gov't
Langues
eng
Sous-ensembles de citation
IM
Pagination
417-427Commentaires et corrections
Type : CommentIn
Informations de copyright
Copyright © 2021 Elsevier Ltd. All rights reserved.
Références
Lancet Infect Dis. 2021 Mar;21(3):344-353
pubmed: 33306981
Lancet Child Adolesc Health. 2020 May;4(5):397-404
pubmed: 32272089
Arch Dis Child. 2020 Jul;105(7):613-615
pubmed: 32381519
Nat Commun. 2021 Feb 10;12(1):905
pubmed: 33568663
N Engl J Med. 2020 Sep 3;383(10):981-985
pubmed: 32726550
EClinicalMedicine. 2020 Jun 03;23:100404
pubmed: 32632416
Arch Dis Child. 2020 Jul;105(7):618-619
pubmed: 32371442
China CDC Wkly. 2020 Jun 19;2(25):453-457
pubmed: 34594677
Euro Surveill. 2020 Jul;25(29):
pubmed: 32720636
EClinicalMedicine. 2020 Nov;28:100597
pubmed: 33173854
Arch Dis Child. 2020 Dec;105(12):1180-1185
pubmed: 32796006
J Infect. 2020 Dec;81(6):979-997
pubmed: 32858069
Arch Dis Child. 2021 Feb;106(2):111-113
pubmed: 32747375
JAMA. 2020 Apr 7;323(13):1239-1242
pubmed: 32091533
N Engl J Med. 2020 Jun 11;382(24):2302-2315
pubmed: 32289214
PLoS One. 2014 May 15;9(5):e97297
pubmed: 24830407
JAMA Pediatr. 2021 Feb 1;175(2):143-156
pubmed: 32975552
Lancet Infect Dis. 2009 Aug;9(8):473-81
pubmed: 19628172
Emerg Infect Dis. 2020 Oct;26(10):2465-2468
pubmed: 32673193
EClinicalMedicine. 2020 Sep;26:100533
pubmed: 32923993